Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival

(2014) Brian L. McClune et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts

(2014) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Experts’ considerations on HLA-haploidentical stem cell transplantation

(2014) Francesca Patriarca et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

(2014) Christopher G. Kanakry et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma

(2013) Jennifer A. Kanakry et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

(2012) R Devillier et al.   BONE MARROW TRANSPLANTATION

Comparative Outcomes of Donor Graft CD34+Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

(2012) Marcelo C. Pasquini et al.   JOURNAL OF CLINICAL ONCOLOGY

Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

(2012) Leo Luznik et al.   SEMINARS IN ONCOLOGY

High-dose cyclophosphamide for graft-versus-host disease prevention

(2010) Leo Luznik et al.   CURRENT OPINION IN HEMATOLOGY

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

(2009) Yvette L. Kasamon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

(2009) Anne Sirvent et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin's Lymphoma

(2007) Andrew R. Rezvani et al.   JOURNAL OF CLINICAL ONCOLOGY